Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sam Whiting, MD, PhD
Calithera Biosciences, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Honor Health
Scottsdale, Arizona, United States
- Stanford University
Palo Alto, California, United States
- University of Colorado
Aurora, Colorado, United States
- University Cancer Blood Center
Athens, Georgia, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Karmanos Caner Center
Detroit, Michigan, United States
- Columbia University Medical Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- New York University
New York, New York, United States
- University Hospitals Cleveland
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Seattle Cancer Care Alliance/university of Washington
Seattle, Washington, United States
- Northwest Medical Specialties
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Aug 2016
- Primary completion
- 24 Apr 2020
- Completion
- 24 Apr 2020
- Last update posted
- 17 Mar 2023
- Registered enrollment
- 118
- Registry id
- NCT02771626
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.